Drug: bevacizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 786 Number of Pages: 40
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Neutropenia | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Proteinuria | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Thrombocytopenia | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Toxic neuropathy | 1 | view events |
| BEVACIZUMAB, 1.25MG/0.05ML | Instillation site reaction | 1 | view events |
| BEVACIZUMAB, 1.25MG/0.05ML | Vitreous floaters | 1 | view events |
Total Drug/Injury Combinations: 786 Number of Pages: 40
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)